Keep calves healthy for a lifetime of performance.

Species:

References

  • 1 Dairy 2007 Part II: Changes in the U.S. Dairy Cattle Industry, 1991-2007. National Animal Health Monitoring Service, U.S. Department of Agriculture. Available at http://www.aphis.usda.gov/animal_health/nahms/dairy/downloads/dairy07/Dairy07_ir_CalfHealth.pdf. Accessed March 15, 2012.
  • 2 Dairy 2007: Heifer Calf Health and Management Practices on U.S. Dairy Operations, 2007. National Animal Health Monitoring Service, U.S. Department of Agriculture. Available at: www.aphis.usda.gov/animal_health/nahms/dairy/downloads/dairy07/Dairy07_ir_CalfHealth.pdf. Accessed May 8, 2012.
  • 3 Lormore M. The case for a quality dairy replacement program, in Proceedings. NRAES Dairy Calves and Heifers: Integrating Biology and Management Conference, 2005.
  • 4 Zoetis Internal On-farm Performance Economic Trial. Effect of tulathromycin use at weaning on bovine respiratory disease and weight gain in Holstein heifer calves. Data on file. February 2, 2010.
  • 5 Freedom of Information Summary for DRAXXIN (tulathromycin) Injectable Solution: NADA 141-244.
  • 6 Zoetis. Efficacy of DRAXXIN administered to calves 9, 7, 5, 3 or 1 day before challenge with Mannheimia haemolytica. Technical Bulletin No. DRX06052, New York: Zoetis, 2006:1-3.
  • 7 Data on file, Study Report No. 1133R-60-09-749, Zoetis Inc.
  • 8 Zoetis. Efficacy of DRAXXIN, followed by 7-, 10-, or 14-day post-treatment intervals, against naturally occurring bovine respiratory disease in high-risk calves to close. Technical Bulletin No. DRX06053, New York: Zoetis, 2007:1-5.
  • 9 Robb EJ, Tucker CM, Corley L, et al. Efficacy of Tulathromycin versus Enrofloxacin for Initial Treatment of Naturally Occurring Bovine Respiratory Disease in Feeder Calves. Vet Ther 2007;8(2):127-135.
  • 10 Skogerboe TL, Rooney KA, Nutsch RG, Weigel DJ, Gajewski K, Kilgore WR. Comparative efficacy of tulathromycin versus florfenicol and tilmicosin against undifferentiated bovine respiratory disease in feedlot cattle. Vet Ther 2005;6(2):180-196.
  • 11 Nutsch RG, Skogerboe TL, Rooney KA, Weigel DJ, Gajewski K, Lectenberg KF. Comparative efficacy of tulathromycin, tilmicosin, and florfenicol in the treatment of bovine respiratory disease in stocker cattle. Vet Ther 2005;6(2):167-179.
  • 12 Rooney KA, Nutsch RG, Skogerboe TL, Weigel DJ, Gajewski K, Kilgore WR. Efficacy of tulathromycin compared with tilmicosin and florfenicol for the control of respiratory disease in cattle at high risk of developing bovine respiratory disease. Vet Ther 2005;6(2):154-166.
  • 13 Stanton AL, Kelton DF, Leblanc SJ, et al. The effect of treatment with long-acting antibiotic at postweaning movement on respiratory disease and on growth in commercial dairy calves. J Dairy Sci 2010;93(2):574-581.
  • 14 Data on file, Study Report No. 09PETDRA05, Zoetis Inc.
Important Safety Information: Do not use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal. A pre-slaughter withdrawal time has not been determined for pre-ruminating calves. Effects on reproductive performance, pregnancy and lactation have not been determined. DRAXXIN has a pre-slaughter withdrawal time of 18 days.

Dairy Wellness Makes a Difference?